Recruiting

Storytelling Interventions

Sponsor:

University of Delaware

Code:

NCT07071077

Conditions

Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Web-Based Storytelling Intervention

Group-Based Storytelling Plus Intervention

Study Details

Brief summary:

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Conditions

Hypertension

Study ID

NCT07071077

Start date

Jan 29, 2025

Status verified date

Jul, 2025

Completion date

May 31, 2026

Anticipated

Primary completion date

May 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • African American/Black
  • Diagnosed with Hypertension
  • Prescribed medication for hypertension

Exclusion Criteria:

  • Cognitive limitations that limit the ability to provide informed consent
  • Pregnancy
  • Unable to speak or read English
  • Planning to relocate during the study period

Study Design

Enrollment

60 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

no intervention: Usual Care

experimental: Storytelling (Web-based Storytelling)

experimental: Storytelling Plus (Group-based Storytelling)

Interventions

Web-Based Storytelling Intervention

The Web-based storytelling group will access stories and educational materials on the study website.

Group-Based Storytelling Plus Intervention

The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Primary outcome measure

  • Systolic and Diastolic Blood Pressure [ Time Frame: 6 months ]
  • Adherence to Antihypertensive Medications (daily usage) [ Time Frame: 6 months ]
  • Adherence to Antihypertensive Medications (self reported) [ Time Frame: 6 months ]

Central Contacts and Locations

Locations

University of Delaware

Recruiting

Newark, Delaware, United States, 19713

Contacts

Yendelela Cuffee

302-831-1302ylcuffee@udel.edu

Principal Investigator:

Yendelela Cuffee

More Information

Sponsor

University of Delaware

Last update posted

Jul 17, 2025

Last verified

Jul, 2025

Keywords

  • Medication Adherence
  • Lifestyle Intervention
  • Behavioral Change

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Delaware on 2025-07-17.